Aspirin's Impact on Lumbar Degeneration
Author Information
Author(s): Niu Haiyun, Zu Feiyu, Shang Zhenguo, Gao Ze, Miao Dazhuang, Zhang Di
Primary Institution: Hebei Medical University Third Hospital, Shijiazhuang City, Hebei, China
Hypothesis
Does aspirin influence lumbar degeneration in patients with low back pain and atherosclerosis?
Conclusion
Aspirin treatment appears to protect against degeneration in the upper lumbar spine, but its effect on the lower lumbar spine is less clear.
Supporting Evidence
- The aspirin group had lower subcutaneous fat tissue thickness and reduced incidence of Modic changes compared to the control group.
- Modified Pfirrmann grading scores were lower in the aspirin group, indicating less severe degeneration.
- Statistically significant differences were found in paravertebral muscle fat infiltration area between the two groups.
Takeaway
Taking aspirin might help keep your back healthier, especially the upper part, but it doesn't seem to help as much with the lower part.
Methodology
The study used propensity score matching to compare 73 patients taking aspirin with 73 control patients, analyzing various imaging metrics.
Potential Biases
Potential biases due to the retrospective design and single-center nature of the study.
Limitations
The study is retrospective, single-centered, and has a small sample size.
Participant Demographics
Patients aged 18 and older with low back pain and atherosclerosis.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website